Wealthcare Advisory Partners’s Idexx Laboratories IDXX Stock Holding History

Wealthcare Advisory Partners’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-33	Closed	-$16K	–	1156
2021 Q1	$16K	Buy	+33	New	+$16.5K	﹤0.01%	1290
2020 Q1	–	Sell	-43	Closed	-$11K	–	1535
2019 Q4	$11K	Hold	43	–	–	﹤0.01%	913
2019 Q3	$12K	Hold	43	–	–	﹤0.01%	880
2019 Q2	$12K	Hold	43	–	–	﹤0.01%	862
2019 Q1	$10K	Hold	43	–	–	﹤0.01%	812
2018 Q4	$8K	Hold	43	–	–	﹤0.01%	837
2018 Q3	$11K	Hold	43	–	–	﹤0.01%	818
2018 Q2	$9K	Buy	+43	New	+$8.86K	﹤0.01%	863

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wealthcare Advisory Partners's IDXX Position: Q2 2021 in Review

Wealthcare Advisory Partners sold out of Idexx Laboratories (IDXX) in Q2 2021, closing a stake of 33 shares — an estimated $16K sold.

Wealthcare Advisory Partners first reported a position in IDXX in Q2 2018 and held it in 8 quarters. The position peaked at $16K in Q1 2021. 1,034 funds tracked by Wall St. Rank hold IDXX as of Q2 2021.

Wealthcare Advisory Partners reported no remaining Idexx Laboratories position as of Q2 2021 after selling out during the quarter.
Wealthcare Advisory Partners sold 33 Idexx Laboratories shares in Q2 2021, an estimated $16K.
Wealthcare Advisory Partners first reported a position in Idexx Laboratories in Q2 2018 and held it in 8 quarters.
Wealthcare Advisory Partners's Idexx Laboratories position peaked at $16K in Q1 2021.
1,034 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2021.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2021, filed 16 Aug 2021.